Evidence map›Paper›PMID 40392156›Full record

ReviewCanadian Urological Association journal = Journal de l'Association des urologues du Canada2025

Comparative effectiveness of en-bloc vs. conventional transurethral resection for non-muscle-invasive bladder cancer A systematic review and meta-analysis.

David E Hinojosa-Gonzalez, Gal Saffati, Troy La, Jackson Cathey, Juan C Angulo-Lozano, Gustavo Salgado-Garza, Jonathan Walsh, Bailey Slawin, Shane Kronstedt, Kate Lowrey and 1 more

Abstract readReview
In one paragraph

Review in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

David E Hinojosa-GonzalezScott Department of Urology, Baylor College of Medicine, Houston, TX, United States.
Gal SaffatiScott Department of Urology, Baylor College of Medicine, Houston, TX, United States.
Troy LaScott Department of Urology, Baylor College of Medicine, Houston, TX, United States.
Jackson CatheyDuke University School of Medicine, Durham, NC, United States.
Juan C Angulo-LozanoDepartment of Urology, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY, United States.
Gustavo Salgado-GarzaOregon Health and Sciences University, Portland, OR, United States.
Jonathan WalshScott Department of Urology, Baylor College of Medicine, Houston, TX, United States.
Bailey SlawinMcGovern Medical School at UTHealth, Houston, TX, United States.
Shane KronstedtScott Department of Urology, Baylor College of Medicine, Houston, TX, United States.
Kate LowreyScott Department of Urology, Baylor College of Medicine, Houston, TX, United States.
Jeremy R SlawinScott Department of Urology, Baylor College of Medicine, Houston, TX, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTransurethral en-bloc resection of bladder tumor (ERBT) has emerged as an alternate technique to conventional transurethral resection of bladder tumor (cTURBT). While theoretically advantageous, the comparative effectiveness of ERBT across various technical approaches remains unclear. We performed an updated systematic review and meta-analysis to evaluate perioperative, pathologic, and oncologic outcomes of ERBT vs. cTURBT.

methodsWe systematically searched PubMed, EMBASE, Scopus, and Google Scholar for randomized controlled trials (RCTs) comparing ERBT and cTURBT. The primary outcome was recurrence-free survival (RFS). Secondary outcomes were operative time, complication rates, detrusor muscle presence, and need for repeated resection. Meta-analyses were performed, with subgroup analyses stratified by ERBT technique.

resultsA total of 10 RCTs with 1973 patients (1012 ERBT, 961 cTURBT) were included. Overall data favored ERBT in RFS (hazard ratio [HR] 0.85, 95% confidence interval [CI] 0.71-1.01, p=0.07, I

conclusionsERBT might have oncologic and perioperative benefits, in addition to technical advantages, relative to cTURBT. Variations in resection instruments used impact the consistency of results.

Identifiers

PMID40392156
PMCPMC12453885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.